【电报解读】瑞德西韦开始临床试验，火速整理这些“特效药”相关公司最新回应（附表）

七印授权

385DNVM0ROU04VMF0T0LGOEV7FZXR0WSY7L8W85UNKJ2EEZGSP

2021-03-05 08:10:41

article

F7CD2F6CFC01F4198A4A0CDCF3A78C2A842A2AF3B7EBF737B99C408F5D4E75C5

zh-CN

FD7ECEC50DE0F3AFA4AC3BC710136BE57B828D65

9241663

02636d79fc7c7cc37b9cb348037eec28743d030e5d570d0d69837a3587bed31880

610a2146bc0bd1a91c1ac0352d50994d3061501ac8591efaf08d7f0903a1cc736caaef54835e0146a2d7119be2a9789b619af18ba21cb98a6f5f8afe4f88a6ca1b

{"parameters":{"adaptation":"sa","commercial":"n"},"type":"cc"}

yuanben_6041e785441159.80289673

原本认证

https://www.yuanben.io/article/be57a167-81dd-45a6-ab13-4564e73daff4

{"author":"财联社","authorization_pub_key":"0233c6594f619ab2bc6f6d7b56a39f700c2fca37e71ae9483c5d5b750f22bc1bbc"}